ArticleBioinformatics (Oxford, England)2026
PLXFPred: interpretable cross-attention networks with hierarchical fusion of multi-modal features for predicting protein-ligand interactions and affinities.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
summaryAccurately predicting protein-ligand interactions and binding affinities is essential for advancing structural biology. Despite recent advancements in deep learning, achieving rapid and precise predictions remains a challenging task. Our approach, Protein-Ligand Cross-Modal Fusion Predictor (PLXFPred), extracts physicochemical properties from amino acid sequences and SMILES. Additionally, it leverages pre-trained models to derive high-dimensional features. GATv2 and BILSTM were used to process the structural and sequence features, respectively. The model's core involves fusing sequence and graph features via a cross-modal cross-attention mechanism, followed by a multi-modal hierarchical fusion strategy that integrates high-level graph, early fusion, and cross-fusion features. Residual connections and conditional domain adversarial learning improve generalization to previously unseen protein-ligand pairs. Compared to state-of-the-art models, PLXFPred demonstrates superior performance, reducing errors (RMSD, MAE, SD) by over 50%, while providing interpretable biological insights through attention weight visualization and SHAP analysis. AVAILABILITY AND IMPLEMENTATION: The resource codes are available at https://github.com/xiyuyangtuo/PLXFPred/.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.